{
    "title": "British drug firms fight to be first in race to beat Covid: Glaxosmithkline teams-up with French rival Sanofi",
    "url": "https://www.dailymail.co.uk/money/markets/article-8218449/British-drug-firms-fight-race-beat-Covid.html",
    "date": "2020-04-14",
    "keywords": [
        "yesterday",
        "sanofi",
        "share",
        "tieup",
        "vaccine",
        "fund",
        "drug",
        "battle",
        "covid19",
        "glaxos",
        "cancer",
        "virus",
        "firm",
        "cent",
        "technology",
        "boss",
        "glaxo",
        "cambridge",
        "calquence",
        "investment",
        "account",
        "fee",
        "centre",
        "coronavirus",
        "vaccinesglaxosmithkline",
        "astrazeneca",
        "rival",
        "glaxosmithkline",
        "vaccineand",
        "involvement",
        "testing",
        "regime",
        "year",
        "centglaxos",
        "announcement",
        "banking",
        "giant",
        "jpmorgan",
        "cargo",
        "hub",
        "pharma",
        "rescue",
        "cost",
        "imf",
        "article",
        "world",
        "technologiesthis",
        "adjuvant",
        "dna",
        "recombinant",
        "productionemma",
        "walmsley",
        "science",
        "effort",
        "paul",
        "hudson",
        "company",
        "laboratory",
        "astraastra",
        "blood",
        "potential",
        "overreaction",
        "immune",
        "system",
        "cytokine",
        "stormbut",
        "control",
        "novacyt",
        "start",
        "astra",
        "lab",
        "diy",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}